Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Oral interferon to enter human trials for MS

March 2, 1999

French investigators describe potent and selective dopamine D3 agonists

March 1, 1999

Potent nAChR receptor agonists with heterocyclic structure patented by Astra

March 1, 1999

CNS compounds from Merck acting on serotonergic system

Feb. 26, 1999

Novel BK channel modulators developed at Bristol-Myers Squibb

Feb. 26, 1999

AutoImmune and Teva to collaborate on oral immune therapies

Feb. 25, 1999

Status updated for Esteve's atypical antipsychotic E-5842

Feb. 25, 1999

New compounds from Pharmacia & Upjohn interfere in the kynurenine metabolic pathway

Feb. 25, 1999

Orphan Medical begins Treatment IND trial of Xyrem in narcolepsy

Feb. 25, 1999

Apollo and AHP to develop estrogen products for Alzheimer's therapy

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...